サンプル依頼リスト カート
  • English
  • Traditional Chinese
  • Simplified Chinese
市場調査レポート
商品コード
1287675

プラセンタの市場シェア、規模、動向、産業分析レポート、タイプ別（豚、馬、羊、その他）、用途別、地域別、セグメント別予測、2023-2032年

Placenta Market Share, Size, Trends, Industry Analysis Report, By Type (Porcine, Equine, Ovine, Others); By Application; By Region; Segment Forecast, 2023-2032
出版日: | 発行: Polaris Market Research | ページ情報: 英文 116 Pages | 納期: 即日から翌営業日

● お客様のご希望に応じて、既存データの加工や未掲載情報（例：国別セグメント）の追加などの対応が可能です。　 詳細はお問い合わせください。
価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=156.76円
プラセンタの市場シェア、規模、動向、産業分析レポート、タイプ別（豚、馬、羊、その他）、用途別、地域別、セグメント別予測、2023-2032年
出版日: 2023年04月01日
発行: Polaris Market Research
ページ情報: 英文 116 Pages
納期: 即日から翌営業日
  • 全表示
  • 概要
  • 図表
  • 目次
概要

Polaris market researchの新しい調査によると、世界のプラセンタ市場規模は2032年までに2億3,601万米ドルに達すると予想されています。本レポートでは、現在の市場力学を詳細に洞察し、将来の市場成長に関する分析を提供しています。

プラセンタ市場を牽引する主な要因の1つは、皮膚の若返りやアンチエイジング製品に対する需要の増加です。1世紀以上にわたって、創傷ケアや傷の治癒は、胎盤に含まれる豊富な幹細胞の活用によって助けられてきました。特に羊膜に含まれる成長因子と抗炎症タンパク質の強力な組み合わせは、体が病気や怪我をしたときに細胞と相互作用するのを助けることができます。

胎盤細胞の正常な機能は、再生薬の助けを借りて回復させることができます。慢性疾患に対する効果的な治療法は、この分野の迅速な改善によって可能になると予測されます。例えば、2022年に発表されたYifeng Linの研究論文によると、ヒトの胎盤から生成された間葉系幹細胞は、多くの利点を持つ新しい代替的なMSCs源です。その治療効果と潜在的な基礎メカニズムをさらに理解するために、HP-MSCを架橋ヒアルロン酸ハイドロゲルで注入し、子宮内への保持を最適化しました。

市場拡大の主な要因の1つは、多額の研究開発投資です。また、予測期間中に病気の負担を軽減するための強力な治療法へのニーズが高まっていることも、成長を後押しする要因となっています。例えば、Felor Biniazanによる2022年の調査では、マウス傷害モデルにおける創傷治癒プロセスおよびTGF誘導瘢痕形成に対する胎盤ベースの羊膜上皮細胞の効果を調査しました。

例えば、2022年に発表されたKirat Chandの調査研究によると、hPD-MSC療法は、代謝物やタンパク質レベル、老化や若返りの血清バイオマーカーに変化をもたらすとされています。驚いたことに、hPD-MSC療法は、ビタミンB6の代謝速度が速くなるため、セロトニン合成を促進しました。肝細胞の増殖やミトコンドリア生合成に関連するmRNAやタンパク質の発現は、注入療法を繰り返すことで肝臓のセロトニン濃度が上昇することで変化しました。hPD-MSC療法を受けた後の血中代謝物の変化から、加齢や若返りのバイオマーカーを見つけることができます。また、セロトニンは、加齢による肝臓の衰えを改善するための重要な治療ターゲットとなります。

プラセンタ市場レポートハイライト

  • 2022年、Ovineが市場全体を支配し、主要な売上高を占めています。プラセンタエキスを含む栄養補助食品、医薬品、化粧品への需要の高まりが、市場拡大の原因となっています。
  • 2022年には、製薬業界が市場を独占していました。市場を牽引する重要な要因は、臨床試験の増加、戦略的イニシアチブの増加、慢性疾患の有病率の増加、ヘルスケアサービスの改善です。
  • 2022年には北米が最大の売上を占める。市場を牽引する主な要因としては、北米の強固なバイオテクノロジー部門、大手企業の存在、多大な研究開発、個別化医療の推進などが挙げられます。
  • 世界の市場参入企業としては、Brroklyn Placenta Services、Atlanta Placenta、MiMedx Group、TelaGen、Thimba Li、Agri-Labco-Productsが挙げられます。

目次

第1章 イントロダクション

第2章 エグゼクティブサマリー

第3章 調査手法

第4章 世界のプラセンタ市場に関する洞察

  • プラセンタ市場- 業界スナップショット
  • プラセンタ市場力学
    • 促進要因と機会
      • エネルギー生産のための再生可能エネルギー源の使用の増加
      • 燃料電池需要の高まり
    • 抑制要因と課題
      • 高コスト生産
  • PESTLE分析
  • プラセンタ業界の動向
  • バリューチェーン分析
  • COVID-19の影響分析

第5章 世界のプラセンタ市場、タイプ別

  • 主な調査結果
  • イントロダクション
  • ブタ
  • 馬
  • ヒツジ
  • その他

第6章 世界のプラセンタ市場、用途別

  • 主な調査結果
  • イントロダクション
  • 医薬品
  • 化粧品
  • サプリメント
  • その他

第7章 世界のプラセンタ市場、地域別

  • 主な調査結果
  • イントロダクション
    • プラセンタ市場評価、地域別、2019-2032年
  • プラセンタ市場-北米
    • 北米：プラセンタ市場、用途別、2019-2032年
    • 北米：プラセンタ市場、種類別、2019-2032年
    • プラセンタ市場-米国
    • プラセンタ市場-カナダ
  • プラセンタ市場- 欧州
    • 欧州：プラセンタ市場、用途別、2019-2032年
    • 欧州：プラセンタ市場、タイプ別、2019-2032
    • プラセンタ市場- 英国
    • プラセンタ市場-フランス
    • プラセンタ市場- ドイツ
    • プラセンタ市場-イタリア
    • プラセンタ市場-スペイン
    • プラセンタ市場-オランダ
    • プラセンタ市場- ロシア
  • プラセンタ市場- アジア太平洋
    • アジア太平洋：プラセンタ市場、用途別、2019～2032年
    • アジア太平洋：プラセンタ市場、タイプ別、2019-2032
    • プラセンタ市場- 中国
    • プラセンタ市場- インド
    • プラセンタ市場-マレーシア
    • プラセンタ市場- 日本
    • プラセンタ市場- インドネシア
    • プラセンタ市場- 韓国
  • プラセンタ市場-中東およびアフリカ
    • 中東およびアフリカ：プラセンタ市場、用途別、2019-2032年
    • 中東およびアフリカ：プラセンタ市場、タイプ別、2019-2032
    • プラセンタ市場-サウジアラビア
    • プラセンタ市場- アラブ首長国連邦
    • プラセンタ市場- イスラエル
    • プラセンタ市場- 南アフリカ
  • プラセンタ市場-ラテンアメリカ
    • ラテンアメリカ：プラセンタ市場、用途別、2019-2032年
    • ラテンアメリカ：プラセンタ市場、種類別、2019-2032年
    • プラセンタ市場-メキシコ
    • プラセンタ市場- ブラジル
    • プラセンタ市場-アルゼンチン

第8章 競合情勢

  • 拡張と買収の分析
    • 拡張
    • 買収
  • 提携/協業/合意/公開

第9章 企業プロファイル

  • Japan Natural Laboratories Co.Ltd
  • Japan Bio Products Co.Ltd
  • BIOON
  • CJT
  • Brroklyn Placenta Services
  • Atlanta Placenta
  • MiMedx Group, Inc
  • TelaGen
  • Thimba Li
  • Agri-Labco-Products
図表

List of Tables

  • Table 1 Global Placenta Market, by Application, 2019-2032 (USD Million)
  • Table 2 Global Placenta Market, by Type, 2019-2032 (USD Million)
  • Table 3 Placenta Market Assessment, By Geography, 2019-2032 (USD Million)
  • Table 4 North America: Placenta Market, by Application, 2019-2032 (USD Million)
  • Table 5 North America: Placenta Market, by Type, 2019-2032 (USD Million)
  • Table 6 U.S.: Placenta Market, by Application, 2019-2032 (USD Million)
  • Table 7 U.S.: Placenta Market, by Type, 2019-2032 (USD Million)
  • Table 8 Canada: Placenta Market, by Application, 2019-2032 (USD Million)
  • Table 9 Canada: Placenta Market, by Type, 2019-2032 (USD Million)
  • Table 10 Europe: Placenta Market, by Application, 2019-2032 (USD Million)
  • Table 11 Europe: Placenta Market, by Type, 2019-2032 (USD Million)
  • Table 12 UK: Placenta Market, by Application, 2019-2032 (USD Million)
  • Table 13 UK: Placenta Market, by Type, 2019-2032 (USD Million)
  • Table 14 France: Placenta Market, by Application, 2019-2032 (USD Million)
  • Table 15 France: Placenta Market, by Type, 2019-2032 (USD Million)
  • Table 16 Germany: Placenta Market, by Application, 2019-2032 (USD Million)
  • Table 17 Germany: Placenta Market, by Type, 2019-2032 (USD Million)
  • Table 18 Italy: Placenta Market, by Application, 2019-2032 (USD Million)
  • Table 19 Italy: Placenta Market, by Type, 2019-2032 (USD Million)
  • Table 20 Spain: Placenta Market, by Application, 2019-2032 (USD Million)
  • Table 21 Spain: Placenta Market, by Type, 2019-2032 (USD Million)
  • Table 22 Netherlands: Placenta Market, by Application, 2019-2032 (USD Million)
  • Table 23 Netherlands: Placenta Market, by Type, 2019-2032 (USD Million)
  • Table 24 Russia: Placenta Market, by Application, 2019-2032 (USD Million)
  • Table 25 Russia: Placenta Market, by Type, 2019-2032 (USD Million)
  • Table 26 Asia Pacific: Placenta Market, by Application, 2019-2032 (USD Million)
  • Table 27 Asia Pacific: Placenta Market, by Type, 2019-2032 (USD Million)
  • Table 28 China: Placenta Market, by Application, 2019-2032 (USD Million)
  • Table 29 China: Placenta Market, by Type, 2019-2032 (USD Million)
  • Table 30 India: Placenta Market, by Application, 2019-2032 (USD Million)
  • Table 31 India: Placenta Market, by Type, 2019-2032 (USD Million)
  • Table 32 Malaysia: Placenta Market, by Application, 2019-2032 (USD Million)
  • Table 33 Malaysia: Placenta Market, by Type, 2019-2032 (USD Million)
  • Table 34 Japan: Placenta Market, by Application, 2019-2032 (USD Million)
  • Table 35 Japan: Placenta Market, by Type, 2019-2032 (USD Million)
  • Table 36 Indonesia: Placenta Market, by Application, 2019-2032 (USD Million)
  • Table 37 Indonesia: Placenta Market, by Type, 2019-2032 (USD Million)
  • Table 38 South Korea: Placenta Market, by Application, 2019-2032 (USD Million)
  • Table 39 South Korea: Placenta Market, by Type, 2019-2032 (USD Million)
  • Table 40 Middle East & Africa: Placenta Market, by Application, 2019-2032 (USD Million)
  • Table 41 Middle East & Africa: Placenta Market, by Type, 2019-2032 (USD Million)
  • Table 42 Saudi Arabia: Placenta Market, by Application, 2019-2032 (USD Million)
  • Table 43 Saudi Arabia: Placenta Market, by Type, 2019-2032 (USD Million)
  • Table 44 UAE: Placenta Market, by Application, 2019-2032 (USD Million)
  • Table 45 UAE: Placenta Market, by Type, 2019-2032 (USD Million)
  • Table 46 Israel: Placenta Market, by Application, 2019-2032 (USD Million)
  • Table 47 Israel: Placenta Market, by Type, 2019-2032 (USD Million)
  • Table 48 South Africa: Placenta Market, by Application, 2019-2032 (USD Million)
  • Table 49 South Africa: Placenta Market, by Type, 2019-2032 (USD Million)
  • Table 50 Latin America: Placenta Market, by Application, 2019-2032 (USD Million)
  • Table 51 Latin America: Placenta Market, by Type, 2019-2032 (USD Million)
  • Table 52 Mexico: Placenta Market, by Application, 2019-2032 (USD Million)
  • Table 53 Mexico: Placenta Market, by Type, 2019-2032 (USD Million)
  • Table 54 Brazil: Placenta Market, by Application, 2019-2032 (USD Million)
  • Table 55 Brazil: Placenta Market, by Type, 2019-2032 (USD Million)
  • Table 56 Argentina: Placenta Market, by Application, 2019-2032 (USD Million)
  • Table 57 Argentina: Placenta Market, by Type, 2019-2032 (USD Million)

List of Figures

  • Figure 1 Global Placenta Market, 2019-2032 (USD Million)
  • Figure 2 Integrated Ecosystem
  • Figure 3 Research Methodology: Top-Down & Bottom-Up Approach
  • Figure 4 Market by Geography
  • Figure 5 Porter's Five Forces
  • Figure 6 Market by Application
  • Figure 7 Global Placenta Market, by Application, 2022 & 2032 (USD Million)
  • Figure 8 Market by Type
  • Figure 9 Global Placenta Market, by Type, 2022 & 2032 (USD Million)
  • Figure 10 Placenta Market Assessment, By Geography, 2019-2032 (USD Million)
  • Figure 11 Strategic Analysis - Placenta Market
目次
Product Code: PM3162

The global placenta market size is expected to reach USD 236.01 Million by 2032, according to a new study by Polaris market research. The report "Placenta Market Share, Size, Trends, Industry Analysis Report, By Type (Porcine, Equine, Ovine, Others); By Application; By Region; Segment Forecast, 2023-2032" gives a detailed insight into current market dynamics and provides analysis on future market growth.

One of the main factors driving the placenta market is the increase in demand for skin-rejuvenating and anti-aging products. For more than a century, wound care and wound healing have been aided by the utilization of the abundant stem cells found in the placenta. A potent combination of growth factors and anti-inflammatory proteins, in particular, found in the amniotic membrane, can help the body interact with cells when it is ill or injured.

The normal function of placenta cells can be restored with the aid of regenerative drugs. Effective treatments for chronic illnesses are projected to be made possible by the field's quick improvements. For instance, mesenchymal stem cells generated from human placentas are a new alternative source of MSCs with a number of benefits, according to a research article by Yifeng Lin published in 2022. In order to further understand their therapeutic effectiveness and potential underlying mechanisms, we infused HP-MSCs with cross-linked hyaluronic acid hydrogel to optimize their retention inside the uterus.

One of the key drivers of market expansion is significant R&D investments. In addition, the growing need for potent treatments to lessen the burden of disease during the predicted period is another factor fueling the growth. For instance, a 2022 research study by Felor Biniazan examined the effects of the placenta based amniotic epithelial cells on wound healing process & TGF induced scar formation in a murine injury model.

For instance, according to a research study by Kirat Chand that was published in 2022, hPD-MSC therapy causes changes in metabolite and protein levels as well as serum biomarker(s) of ageing and/or rejuvenation. Surprisingly, hPD-MSC treatment boosted serotonin synthesis due to faster rates of vitamin B6 metabolism. The expression of mRNAs and proteins linked to hepatocyte proliferation and mitochondrial biogenesis was changed by elevated liver serotonin levels following repeated injection therapy. After receiving hPD-MSC therapy, metabolite changes in the blood can be used to find ageing and/or rejuvenation biomarkers. Serotonin is also an important therapeutic target for correcting liver deterioration brought on by ageing.

Placenta Market Report Highlights

  • In 2022, the Ovine dominated the whole market, accounting for major sales revenue. The rising demand for dietary supplements, medicines, and cosmetics that contain placenta extracts is to blame for the market's expansion.
  • The pharmaceutical industry dominated the market, in 2022. The significant factors driving the market are an increase in clinical trials, an increase in strategic initiatives, an increase in the prevalence of chronic diseases, and improvements in healthcare services.
  • North America hold the largest revenue in 2022. The main factors driving the market include North America's robust biotechnology sector, the existence of major players, considerable R&D, and the promotion of personalized medications.
  • The global players with global presence include Brroklyn Placenta Services, Atlanta Placenta, MiMedx Group, TelaGen, Thimba Li, and Agri-Labco-Products.

Polaris Market Research has segmented the Placenta Market report based on product type, application, and region:

Placenta, Type Outlook (Revenue - USD Million, 2019 - 2032)

  • Porcine
  • Equine
  • Ovine
  • Others

Placenta, Application Outlook (Revenue - USD Million, 2019 - 2032)

  • Pharmaceuticals
  • Cosmetics
  • Supplements
  • Others

Placenta, Regional Outlook (Revenue - USD Million, 2019 - 2032)

  • North America
  • U.S.
  • Canada
  • Europe
  • Germany
  • UK
  • France
  • Italy
  • Spain
  • Russia
  • Netherlands
  • Asia Pacific
  • China
  • India
  • Japan
  • South Korea
  • Indonesia
  • Malaysia
  • Latin America
  • Argentina
  • Brazil
  • Mexico
  • Middle East & Africa
  • UAE
  • Saudi Arabia
  • Israel
  • South Africa

Table of Contents

1. Introduction

  • 1.1. Report Description
    • 1.1.1. Objectives of the Study
    • 1.1.2. Market Scope
    • 1.1.3. Assumptions
  • 1.2. Stakeholders

2. Executive Summary

  • 2.1. Market Highlights

3. Research Methodology

  • 3.1. Overview
    • 3.1.1. Data Mining
  • 3.2. Data Sources
    • 3.2.1. Primary Sources
    • 3.2.2. Secondary Sources

4. Global Placenta Market Insights

  • 4.1. Placenta Market - Industry Snapshot
  • 4.2. Placenta Market Dynamics
    • 4.2.1. Drivers and Opportunities
      • 4.2.1.1. Increasing use of renewable energy sources for energy production
      • 4.2.1.2. Rising fuel cell demand
    • 4.2.2. Restraints and Challenges
      • 4.2.2.1. High cost production
  • 4.3. Porter's Five Forces Analysis
    • 4.3.1. Bargaining Power of Suppliers (Moderate)
    • 4.3.2. Threats of New Entrants: (Low)
    • 4.3.3. Bargaining Power of Buyers (Moderate)
    • 4.3.4. Threat of Substitute (Moderate)
    • 4.3.5. Rivalry among existing firms (High)
  • 4.4. PESTLE Analysis
  • 4.5. Placenta Industry trends
  • 4.6. Value Chain Analysis
  • 4.7. COVID-19 Impact Analysis

5. Global Placenta Market, by Type

  • 5.1. Key Findings
  • 5.2. Introduction
    • 5.2.1. Global Placenta, by Type, 2019-2032 (USD Million)
  • 5.3. Porcine
    • 5.3.1. Global Placenta Market, by Porcine, by Region, 2019-2032 (USD Million)
  • 5.4. Equine
    • 5.4.1. Global Placenta Market, by Equine, by Region, 2019-2032 (USD Million)
  • 5.5. Ovine
    • 5.5.1. Global Placenta Market, by Ovine, by Region, 2019-2032 (USD Million)
  • 5.6. Others
    • 5.6.1. Global Placenta Market, by Others, by Region, 2019-2032 (USD Million)

6. Global Placenta Market, by Application

  • 6.1. Key Findings
  • 6.2. Introduction
    • 6.2.1. Global Placenta Market, by Application, 2019-2032 (USD Million)
  • 6.3. Pharmaceuticals
    • 6.3.1. Global Placenta Market, by Pharmaceuticals, by Region, 2019-2032 (USD Million)
  • 6.4. Cosmetics
    • 6.4.1. Global Placenta Market, by Cosmetics, by Region, 2019-2032 (USD Million)
  • 6.5. Supplements
    • 6.5.1. Global Placenta Market, by Supplements, by Region, 2019-2032 (USD Million)
  • 6.6. Others
    • 6.6.1. Global Placenta Market, by Others, by Region, 2019-2032 (USD Million)

7. Global Placenta Market, by Geography

  • 7.1. Key findings
  • 7.2. Introduction
    • 7.2.1. Placenta Market Assessment, By Geography, 2019-2032 (USD Million)
  • 7.3. Placenta Market - North America
    • 7.3.1. North America: Placenta Market, by Application, 2019-2032 (USD Million)
    • 7.3.2. North America: Placenta Market, by Type, 2019-2032 (USD Million)
    • 7.3.3. Placenta Market - U.S.
      • 7.3.3.1. U.S.: Placenta Market, by Application, 2019-2032 (USD Million)
      • 7.3.3.2. U.S.: Placenta Market, by Type, 2019-2032 (USD Million)
    • 7.3.4. Placenta Market - Canada
      • 7.3.4.1. Canada: Placenta Market, by Application, 2019-2032 (USD Million)
      • 7.3.4.2. Canada: Placenta Market, by Type, 2019-2032 (USD Million)
  • 7.4. Placenta Market - Europe
    • 7.4.1. Europe: Placenta Market, by Application, 2019-2032 (USD Million)
    • 7.4.2. Europe: Placenta Market, by Type, 2019-2032 (USD Million)
    • 7.4.3. Placenta Market - UK
      • 7.4.3.1. UK: Placenta Market, by Application, 2019-2032 (USD Million)
      • 7.4.3.2. UK: Placenta Market, by Type, 2019-2032 (USD Million)
    • 7.4.4. Placenta Market - France
      • 7.4.4.1. France: Placenta Market, by Application, 2019-2032 (USD Million)
      • 7.4.4.2. France: Placenta Market, by Type, 2019-2032 (USD Million)
    • 7.4.5. Placenta Market - Germany
      • 7.4.5.1. Germany: Placenta Market, by Application, 2019-2032 (USD Million)
      • 7.4.5.2. Germany: Placenta Market, by Type, 2019-2032 (USD Million)
    • 7.4.6. Placenta Market - Italy
      • 7.4.6.1. Italy: Placenta Market, by Application, 2019-2032 (USD Million)
      • 7.4.6.2. Italy: Placenta Market, by Type, 2019-2032 (USD Million)
    • 7.4.7. Placenta Market - Spain
      • 7.4.7.1. Spain: Placenta Market, by Application, 2019-2032 (USD Million)
      • 7.4.7.2. Spain: Placenta Market, by Type, 2019-2032 (USD Million)
    • 7.4.8. Placenta Market - Netherlands
      • 7.4.8.1. Netherlands: Placenta Market, by Application, 2019-2032 (USD Million)
      • 7.4.8.2. Netherlands: Placenta Market, by Type, 2019-2032 (USD Million)
    • 7.4.9. Placenta Market - Russia
      • 7.4.9.1. Russia: Placenta Market, by Application, 2019-2032 (USD Million)
      • 7.4.9.2. Russia: Placenta Market, by Type, 2019-2032 (USD Million)
  • 7.5. Placenta Market - Asia Pacific
    • 7.5.1. Asia Pacific: Placenta Market, by Application, 2019-2032 (USD Million)
    • 7.5.2. Asia Pacific: Placenta Market, by Type, 2019-2032 (USD Million)
    • 7.5.3. Placenta Market - China
      • 7.5.3.1. China: Placenta Market, by Application, 2019-2032 (USD Million)
      • 7.5.3.2. China: Placenta Market, by Type, 2019-2032 (USD Million)
    • 7.5.4. Placenta Market - India
      • 7.5.4.1. India: Placenta Market, by Application, 2019-2032 (USD Million)
      • 7.5.4.2. India: Placenta Market, by Type, 2019-2032 (USD Million)
    • 7.5.5. Placenta Market - Malaysia
      • 7.5.5.1. Malaysia: Placenta Market, by Application, 2019-2032 (USD Million)
      • 7.5.5.2. Malaysia: Placenta Market, by Type, 2019-2032 (USD Million)
    • 7.5.6. Placenta Market - Japan
      • 7.5.6.1. Japan: Placenta Market, by Application, 2019-2032 (USD Million)
      • 7.5.6.2. Japan: Placenta Market, by Type, 2019-2032 (USD Million)
    • 7.5.7. Placenta Market - Indonesia
      • 7.5.7.1. Indonesia: Placenta Market, by Application, 2019-2032 (USD Million)
      • 7.5.7.2. Indonesia: Placenta Market, by Type, 2019-2032 (USD Million)
    • 7.5.8. Placenta Market - South Korea
      • 7.5.8.1. South Korea: Placenta Market, by Application, 2019-2032 (USD Million)
      • 7.5.8.2. South Korea: Placenta Market, by Type, 2019-2032 (USD Million)
  • 7.6. Placenta Market - Middle East & Africa
    • 7.6.1. Middle East & Africa: Placenta Market, by Application, 2019-2032 (USD Million)
    • 7.6.2. Middle East & Africa: Placenta Market, by Type, 2019-2032 (USD Million)
    • 7.6.3. Placenta Market - Saudi Arabia
      • 7.6.3.1. Saudi Arabia: Placenta Market, by Application, 2019-2032 (USD Million)
      • 7.6.3.2. Saudi Arabia: Placenta Market, by Type, 2019-2032 (USD Million)
    • 7.6.4. Placenta Market - UAE
      • 7.6.4.1. UAE: Placenta Market, by Application, 2019-2032 (USD Million)
      • 7.6.4.2. UAE: Placenta Market, by Type, 2019-2032 (USD Million)
    • 7.6.5. Placenta Market - Israel
      • 7.6.5.1. Israel: Placenta Market, by Application, 2019-2032 (USD Million)
      • 7.6.5.2. Israel: Placenta Market, by Type, 2019-2032 (USD Million)
    • 7.6.6. Placenta Market - South Africa
      • 7.6.6.1. South Africa: Placenta Market, by Application, 2019-2032 (USD Million)
      • 7.6.6.2. South Africa: Placenta Market, by Type, 2019-2032 (USD Million)
  • 7.7. Placenta Market - Latin America
    • 7.7.1. Latin America: Placenta Market, by Application, 2019-2032 (USD Million)
    • 7.7.2. Latin America: Placenta Market, by Type, 2019-2032 (USD Million)
    • 7.7.3. Placenta Market - Mexico
      • 7.7.3.1. Mexico: Placenta Market, by Application, 2019-2032 (USD Million)
      • 7.7.3.2. Mexico: Placenta Market, by Type, 2019-2032 (USD Million)
    • 7.7.4. Placenta Market - Brazil
      • 7.7.4.1. Brazil: Placenta Market, by Application, 2019-2032 (USD Million)
      • 7.7.4.2. Brazil: Placenta Market, by Type, 2019-2032 (USD Million)
    • 7.7.5. Placenta Market - Argentina
      • 7.7.5.1. Argentina: Placenta Market, by Application, 2019-2032 (USD Million)
      • 7.7.5.2. Argentina: Placenta Market, by Type, 2019-2032 (USD Million)

8. Competitive Landscape

  • 8.1. Expansion and Acquisition Analysis
    • 8.1.1. Expansion
    • 8.1.2. Acquisitions
  • 8.2. Partnerships/Collaborations/Agreements/Exhibitions

9. Company Profiles

  • 9.1. Japan Natural Laboratories Co.Ltd
    • 9.1.1. Company Overview
    • 9.1.2. Financial PerTypeance
    • 9.1.3. Type Benchmarking
    • 9.1.4. Recent Development
  • 9.2. Japan Bio Products Co.Ltd
    • 9.2.1. Company Overview
    • 9.2.2. Financial PerTypeance
    • 9.2.3. Type Benchmarking
    • 9.2.4. Recent Development
  • 9.3. BIOON
    • 9.3.1. Company Overview
    • 9.3.2. Financial PerTypeance
    • 9.3.3. Type Benchmarking
    • 9.3.4. Recent Development
  • 9.4. CJT
    • 9.4.1. Company Overview
    • 9.4.2. Financial PerTypeance
    • 9.4.3. Type Benchmarking
    • 9.4.4. Recent Development
  • 9.5. Brroklyn Placenta Services
    • 9.5.1. Company Overview
    • 9.5.2. Financial PerTypeance
    • 9.5.3. Type Benchmarking
    • 9.5.4. Recent Development
  • 9.6. Atlanta Placenta
    • 9.6.1. Company Overview
    • 9.6.2. Financial PerTypeance
    • 9.6.3. Type Benchmarking
    • 9.6.4. Recent Development
  • 9.7. MiMedx Group, Inc
    • 9.7.1. Company Overview
    • 9.7.2. Financial PerTypeance
    • 9.7.3. Type Benchmarking
    • 9.7.4. Recent Development
  • 9.8. TelaGen
    • 9.8.1. Company Overview
    • 9.8.2. Financial PerTypeance
    • 9.8.3. Type Benchmarking
    • 9.8.4. Recent Development
  • 9.9. Thimba Li
    • 9.9.1. Company Overview
    • 9.9.2. Financial PerTypeance
    • 9.9.3. Type Benchmarking
    • 9.9.4. Recent Development
  • 9.10. Agri-Labco-Products
    • 9.10.1. Company Overview
    • 9.10.2. Financial PerTypeance
    • 9.10.3. Type Benchmarking
    • 9.10.4. Recent Development